Video Library

Metastatic Pancreatic Cancer

Dr. George Kim reviews the MPACT study—the largest multinational phase III study in mPAC using ABRAXANE + gemcitabine in the first-line setting
MPACT Trial Design Video
MPACT Trial Design
Dr. Kim presents the trial design and results in the MPACT trial.
MPACT Efficacy Video
MPACT Efficacy
Dr. Kim presents the efficacy results for ABRAXANE in the MPACT trial (including OS, ORR, and PFS).
MPACT Safety Video
MPACT Safety
Dr. Kim presents the safety results for ABRAXANE in the MPACT trial.
MPACT Dosing Video
MPACT Dosing
Dr. Kim presents dosing and schedule recommendations for ABRAXANE in the
MPACT trial.

Metastatic Breast Cancer

ABRAXANE patients discuss their journey with diagnosis and treatment of MBC  
Della discusses her journey living with advanced breast cancer
Della*
Della discusses her journey living with MBC.
Carol and Gene a patient and her caregiver
Carol*
Carol and Gene, a patient and her caregiver, talk about their journey living with MBC.
*Video is also accessible on the ABRAXANE Patient website.

Over a Decade of Real-world Clinical Experience in MBC

Ten Year Anniversary video
ABRAXANE: A history of looking ahead
The story of ABRAXANE told through the experiences of those who have inspired our history.

ABRAXANE Reconstitution Video

This video will guide you through the appropriate process of reconstituting ABRAXANE.

Reconstruction video
Reconstitution Video
This video highlights the key steps and considerations to properly reconstitute ABRAXANE.

Video Library

Metastatic Pancreatic Cancer

Dr. George Kim reviews the MPACT study—the largest multinational phase III study in mPAC using ABRAXANE + gemcitabine in the first-line setting

MPACT Trial Design Video
MPACT Trial Design

Dr. Kim presents the trial design and results in the MPACT trial.

MPACT Efficacy Video
MPACT Efficacy

Dr. Kim presents the efficacy results for ABRAXANE in the MPACT trial (including OS, ORR, and PFS).

MPACT Safety Video
MPACT Safety

Dr. Kim presents the safety results for ABRAXANE in the MPACT trial.

MPACT Dosing Video
MPACT Dosing

Dr. Kim presents dosing and schedule recommendations for ABRAXANE in the MPACT trial.

Celgene Patient Support®

CPS OPM Video

Learn about the changing insurance landscape, and how CPS can help your office staff and patients access Celgene medications.

Metastatic Breast Cancer

ABRAXANE patients discuss their journey with diagnosis and treatment of MBC

Della discusses her journey living with advanced breast cancer
Della*

Della discusses her journey living with MBC.

Carol and Gene a patient and her caregiver
Carol*

Carol and Gene, a patient and her caregiver, talk about their journey living with MBC.

*Video is also accessible on the ABRAXANE Patient website.

Over a Decade of Real-world Clinical Experience in MBC

Ten Year Anniversary video
ABRAXANE: A history of looking ahead

The story of ABRAXANE told through the experiences of those who have inspired our history.

ABRAXANE Reconstitution Video

This video will guide you through the appropriate process of reconstituting ABRAXANE.

Carol and Gene a patient and her caregiver
Reconstitution Video

This video highlights the key steps and considerations to properly reconstitute ABRAXANE.

INDICATIONS

ABRAXANE is indicated for:

  • The treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
  • The first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
  • The first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine

INDICATIONS

ABRAXANE is indicated for:

  • The treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated
  • The first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy
  • The first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine